All In Biotech

Drug Trial Radar · NCT00932451

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Phase 2, Open-label Single Arm Study Of The Efficacy And Safety Of Pf-02341066 In Patients With Advanced Non-small Cell Lung Cancer (Nsclc) Harboring A Translocation Or Inversion Involving The Anaplastic Lymphoma Kinase (Alk) Gene Locus

Last checked: Nov 19, 2026Latest source record: Jan 13, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,069

Actual

Start

Jan 2010

Primary completion

Mar 2015

Study completion Dec 2015

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jul 3, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 trial that will evaluate the safety and efficacy of PF-02341066 in patients with advanced non-small cell lung cancer with a specific gene profile involving the ALK gene. This trial will also allow patients from a Phase 3 trial who received standard of care chemotherapy (Study A8081007) to receive PF-02341066.

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

  • PF-02341066Drug

    PF-02341066, 250 mg BID, will be administered orally on a continuous schedule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response RateTime frame: 6 years
  2. Percentage of Participants With Adverse EventsTime frame: 6 years

Locations

280 sites in 22 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Comprehensive Blood and Cancer Center

    Bakersfield, California

  • Tower Cancer Research Foundation

    Beverly Hills, California

  • Tower Hematology Oncology Medical Group

    Beverly Hills, California

  • Moores UCSD Cancer Center

    La Jolla, California

  • UCSD Medical Center - La Jolla

    La Jolla, California

  • Drug Shipping Address: Ronald Reagen University of California-Los Angeles

    Los Angeles, California

  • Ronald Reagen University of California-Los Angeles Medical Center

    Los Angeles, California

  • UCLA Opthalmic Oncology Center

    Los Angeles, California

  • University of California-Los Angeles

    Los Angeles, California

  • University of California, Irvine-Medical Center

    Orange, California

  • University of California, Irvine-Pharmacy

    Orange, California

  • Stanford University-Cancer Center

    Palo Alto, California

  • UC Davis Cancer Center

    Sacramento, California

  • University of California Davis Medical Center

    Sacramento, California

  • UCSD Medical Center - Hillcrest

    San Diego, California

  • Santa Monica-UCLA Medical Center & Orthopaedic Hospital Clinical Laboratory

    Santa Monica, California

  • UCLA Hematology Oncology-Santa Monica

    Santa Monica, California

  • University of California-Los Angeles

    Santa Monica, California

  • Redwood Regional Medical Group Inc

    Santa Rosa, California

  • DRUG SHIPMENT: University of Colorado Cancer Center

    Aurora, Colorado

  • Rocky Mountain Lions Eye Institute

    Aurora, Colorado

  • University of Colorado Hospital

    Aurora, Colorado

  • Kaiser Permanente Colorado - Franklin

    Denver, Colorado

  • Kaiser Permanente Colorado - Rock Creek

    Lafayette, Colorado

  • Smilow Cancer Center at Yale New Haven, Oncology Pharmacy

    New Haven, Connecticut

  • Smilow Cancer Hospital at Yale New Haven

    New Haven, Connecticut

  • Yale University

    New Haven, Connecticut

  • Michael and Dianne Bienes Cancer Center, Holy Cross Hospital

    Fort Lauderdale, Florida

  • Memorial Cancer Institute

    Hollywood, Florida

  • Cancer Center of South Florida Foundation, Inc.

    Lake Worth, Florida

  • Memorial Cancer Center (West)

    Pembroke Pines, Florida

  • H Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida

  • Emory University Hospital Midtown

    Atlanta, Georgia

  • Emory Clinic

    Atlanta, Georgia

  • Emory University Clinic

    Atlanta, Georgia

  • Emory University Hospital

    Atlanta, Georgia

  • Winship Cancer Institution

    Atlanta, Georgia

Showing 40 of 280 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.